A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
Public ClinicalTrials.gov record NCT05956626. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 1 STUDY TO ASSESS THE SAFETY AND EFFICACY OF OCU410ST FOR STARGARDT DISEASE AND PHASE 2/3 PIVOTAL CONFIRMATORY CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF OCU410ST FOR STARGARDT DISEASE
Study identification
- NCT ID
- NCT05956626
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Ocugen
- Industry
- Enrollment
- 51 participants
Conditions and interventions
Conditions
Interventions
- OCU410ST Drug
Drug
Eligibility (public fields only)
- Age range
- 5 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 24, 2023
- Primary completion
- Sep 27, 2026
- Completion
- Sep 27, 2026
- Last update posted
- Apr 5, 2026
2023 – 2026
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Associated Retina Consultants | Phoenix | Arizona | 85020 | — |
| Retinal Consultants Medical Group | Sacramento | California | 95825 | — |
| Vitreo Retinal Associates, P.A. | Gainesville | Florida | 32607 | — |
| Bascom Palmer Eye Institute | Miami | Florida | 33136 | — |
| Advanced Research, LLC | Pompano Beach | Florida | 33064 | — |
| Retina Partners Midwest, P.C. | Carmel | Indiana | 46032 | — |
| Boston Children's Hospital | Boston | Massachusetts | 02115 | — |
| Mississippi Retina Associates | Jackson | Mississippi | 39202 | — |
| The Retina Institute | St Louis | Missouri | 63128 | — |
| Duke Eye Center | Durham | North Carolina | 27710 | — |
| Erie Retina Research, LLC | Erie | Pennsylvania | 16505 | — |
| Retina Consultants of Texas | Bellaire | Texas | 77401 | — |
| Retina Foundation of the Southwest | Dallas | Texas | 75231 | — |
| Valley Retina Institute | McAllen | Texas | 78503 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05956626, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 5, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05956626 live on ClinicalTrials.gov.